About
Healthcare Edge
Tech Edge
PE Edge
Palm Beach ’24
Research

Analysis

Editors Picks

ReAlta Life Sciences Presents Data for Hypoxic Ischemic Encephalopathy at PAS Meeting 2025

By Karen Roman ReAlta Life Sciences said it is presenting new data from its...

Patient Impact: BioStem Technologies CEO Jason Matuszewski, Live from Nasdaq

Tech Edge hosted a fireside chat on April 22 at Nasdaq MarketSite with Jason...

March Bio Starts Phase 2 Trial for Rare Blood Cancer

By Karen Roman March Biosciences said it started Phase 2 trial for MB-105, its...

Ascentage Pharma Drugs Included in Chinese Society of Clinical Oncology Guidelines

By Karen Roman Ascentage Pharma Group Internat (Nasdaq: AAPG) said two of its proprietary...

Latest Posts

ReAlta Life Sciences Presents Data for Hypoxic Ischemic Encephalopathy at PAS Meeting 2025

Patient Impact: BioStem Technologies CEO Jason Matuszewski, Live from Nasdaq

March Bio Starts Phase 2 Trial for Rare Blood Cancer

Most Popular Posts

LiveVox CEO, Louis Summe, on the Future of Customer Experience and the Contact Center

INTERVIEW: Tula Skincare CEO Savannah Sachs on Adapting to Any Situation

Gryphon Digital Mining CEO Rob Chang on Sustainable Bitcoin Mining

About
Contact Us
Privacy
Site Map

© Copyright 2023, ExecEdge

Input your search keywords and press Enter.

About
Healthcare Edge
Tech Edge
PE Edge
Palm Beach ’24
Research

About
Contact Us
Privacy
Site Map

© Copyright 2023, ExecEdge